🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New in AJMC from Mark Fendrick, MD of UM V-BID Center: a reflection on the tumultuous events of the past week and the broader issues facing American healthcare & insurance: ajmc.com/view/sharing-r…

🚨 Available now 🚨 Discover in this latest analysis the estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening. Click for the full article 👉bit.ly/3ORNuBw John Kisiel UM V-BID Center Derek Ebner M.D.

npr.org/2024/12/12/nx-…. . U-M IHPI

Coverage of Obesity Medications Can Make America Healthier (Again) realclearhealth.com/blog/2024/12/2… vbidcenter.org/initiatives/ob…

UnitedHealth exec’s murder unlikely to change insurer practices modernhealthcare.com/insurance/bria… via Modern Healthcare. U-M IHPI

Coverage of Obesity Medications Can Make America Healthier (Again) aei.org/op-eds/coverag…

The Supreme Court just agreed to hear arguments in a case that could determine the future of no-cost coverage of preventive screenings & medications. Learn more in this #explainer featuring our members Nicholas Bagley and Mark Fendrick from UM V-BID Center . ihpi.umich.edu/news/freeze-or…

In their new Forefront article, A. Mark Fendrick and Kirsten Axelsen from UM V-BID Center argue that, given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish plan-level metrics describing how beneficiaries’ use of medications

In their new Forefront article, Riya Doshi and A. Mark Fendrick of University of Michigan Medical School and University of Michigan discuss how the unwinding of the the Medicare Advantage Value-Based Insurance Design (MA-VBID) Model does not portend the end of the use of V-BID to improve access to high-value services

Podcast: What's Happening with Value-Based Insurance Design? w/ Mark Fendrick | Health Affairs healthaffairs.org/do/10.1377/hp2…. U-M IHPI

New work from our member Diane M Harper Research Group

What Forced CMS to Terminate the MA Value-Base Insurance Design Model? hcinnovationgroup.com/policy-value-b…

Trump casts psychiatric and weight-loss drugs as threats to children ⁦Michigan News⁩ ⁦U-M IHPI⁩ washingtonpost.com/health/2025/02…

AHEAD OF PRINT | The first two years of the COVID-19 pandemic saw an exponential increase in using repurposed medications to treat infections. Michelle S. Rockwell of Virginia Tech and coauthors explore demographic trends driving the surge in prescriptions and spending on

R.I.P. VBID — In Medicare Advantage Alone or Beyond? shar.es/agdYxL U-M IHPI Michigan News

R.I.P. VBID? (Part 2) shar.es/agdzKF

TONIGHT: watch PBSNews.org.org NewsHour for a story on the #SCOTUS case that’s being heard on Monday, with insights from our member Mark Fendrick about the implications for preventive care.

Mark Fendrick, director of Center for Value-Based Insurance Design UM V-BID Center, whose research shows that telehealth decreased the number of cars on the road in the U.S., reducing monthly carbon dioxide emissions by the equivalent of up to 130,000 gas-powered cars. via TIME:

Most viewed this week from JAMA Health Forum: Expanding Medicare coverage for GLP-1RAs for obesity treatment would increase access and reduce obesity-related comorbidities, but would also result in substantial net spending of $47.7 billion over 10 years. ja.ma/42JM7Ne